| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
47,486 |
41,129 |
$10.67M |
| A0425 |
Ground mileage, per statute mile |
106,336 |
78,467 |
$6.44M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
31,064 |
24,883 |
$4.59M |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
24,720 |
18,334 |
$3.24M |
| A0998 |
Ambulance response and treatment, no transport |
12,575 |
11,218 |
$1.95M |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
2,103 |
2,029 |
$482K |
| A0433 |
Advanced life support, level 2 (als 2) |
177 |
172 |
$50K |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
17 |
17 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$4K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
13 |
13 |
$4K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
13 |
13 |
$3K |
| A0422 |
Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation |
2,595 |
2,267 |
$10.48 |
| Q0247 |
Injection, sotrovimab, 500 mg |
15 |
15 |
$0.00 |